| Symbol |
Name |
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ACE
|
angiotensin I converting enzyme
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AIMP1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANKS1B
|
ankyrin repeat and sterile alpha motif domain containing 1B
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOE
|
apolipoprotein E
|
|
ATF4
|
activating transcription factor 4
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLVRA
|
biliverdin reductase A
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C3
|
complement component 3
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN10
|
calpain 10
|
|
CASC5
|
cancer susceptibility candidate 5
|
|
CAT
|
catalase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCND1
|
cyclin D1
|
|
CD14
|
CD14 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD40LG
|
CD40 ligand
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRFAM7A
|
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion
|
|
CHRNA2
|
cholinergic receptor, nicotinic, alpha 2 (neuronal)
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNA6
|
cholinergic receptor, nicotinic, alpha 6 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CLCA1
|
chloride channel accessory 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRHBP
|
corticotropin releasing hormone binding protein
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DEFB4A
|
defensin, beta 4A
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FAM13A
|
family with sequence similarity 13, member A
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FGB
|
fibrinogen beta chain
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTMT
|
ferritin mitochondrial
|
|
GABARAP
|
GABA(A) receptor-associated protein
|
|
GALR1
|
galanin receptor 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GPC5
|
glypican 5
|
|
GPX1
|
glutathione peroxidase 1
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM2
|
glutathione S-transferase mu 2 (muscle)
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HP
|
haptoglobin
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR3B
|
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGHMBP2
|
immunoglobulin mu binding protein 2
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS1
|
insulin receptor substrate 1
|
|
JAK2
|
Janus kinase 2
|
|
KDR
|
kinase insert domain receptor
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
L1TD1
|
LINE-1 type transposase domain containing 1
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LEPR
|
leptin receptor
|
|
LPL
|
lipoprotein lipase
|
|
LTB4R
|
leukotriene B4 receptor
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR149
|
microRNA 149
|
|
MIR181A1
|
microRNA 181a-1
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR199A2
|
microRNA 199a-2
|
|
MIR21
|
microRNA 21
|
|
MIR605
|
microRNA 605
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPPB
|
natriuretic peptide B
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPRM1
|
opioid receptor, mu 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P4HA1
|
prolyl 4-hydroxylase, alpha polypeptide I
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PGF
|
placental growth factor
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PON1
|
paraoxonase 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RORC
|
RAR-related orphan receptor C
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFTPB
|
surfactant protein B
|
|
SFTPD
|
surfactant protein D
|
|
SIRT1
|
sirtuin 1
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRXN1
|
sulfiredoxin 1
|
|
STK11
|
serine/threonine kinase 11
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SUV39H2
|
suppressor of variegation 3-9 homolog 2 (Drosophila)
|
|
SYTL1
|
synaptotagmin-like 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TTC12
|
tetratricopeptide repeat domain 12
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
